The New Federal Hemp Definition: What Section 781 Changes for Shoppers in 2026
The rules that define legal hemp are shifting. In November 2025, the Continuing Appropriations Act, 2026 (P.L. 119-37) rewrote the federal definition of hemp, and its hemp provisions (Section 781) are scheduled to take effect on November 12, 2026. According to a Congressional Research Service analysis, the change moves away from measuring only delta-9 THC on a dry-weight basis and toward a "total THC" concept, while also capping finished consumable products at no more than 0.4 milligrams of total THC per container.
In practical terms, that is a much stricter ceiling than the prior 0.3% delta-9 dry-weight threshold from the 2018 Farm Bill, and it is designed to sweep in intoxicating cannabinoids such as delta-8 that had grown from a regulatory gap. The law carves out genuine industrial hemp grown for fiber, grain, and non-cannabinoid seed derivatives. Several bills, including proposals to strike Section 781 or replace it with a regulated framework, are still moving through Congress, so the details could change before the effective date.
What does this mean for you as a shopper? Expect labels, formulations, and available products to keep evolving over the coming year, and lean harder than ever on batch-matched third-party lab reports. None of this is legal advice, and separate from any of these debates, the FDA has consistently held that CBD is not an approved food additive or dietary ingredient. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Talk with your healthcare provider before using any cannabinoid product.
Zoom out from the policy fight and the market itself tells a steadier story: Grand View Research values the U.S. cannabidiol market at roughly $7.7 billion in 2025, with hemp-derived formulations making up the largest single share — about 53% — of what shoppers actually buy. For a neighborhood shop like ours, that scale cuts both ways. It means real selection and steadily improving product quality, but also a crowded shelf where third-party Certificates of Analysis are the only honest way to tell a carefully made batch from a bargain-bin one. We read the COAs so you don't have to squint at them. None of this is medical advice, and market size says nothing about how any product will affect you: the FDA has consistently held that CBD is not an approved food additive or dietary ingredient, these statements have not been evaluated by the Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease. Talk with your healthcare provider before starting any new wellness routine.
Sources: Congress.gov (CRS); Congress.gov (CRS); FDA; Grand View Research — U.S. CBD Market
